Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Mayne Pharma Group ( (AU:MYX) ) has shared an update.
Mitsubishi UFJ Financial Group, Inc. has ceased to be a substantial holder in Mayne Pharma Group Limited as of July 1, 2025. This change in substantial holding is due to the purchase of securities by an entity controlled by Morgan Stanley, impacting the voting securities associated with Mitsubishi UFJ Financial Group.
The most recent analyst rating on (AU:MYX) stock is a Hold with a A$7.40 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 923,378
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$406.2M
For an in-depth examination of MYX stock, go to TipRanks’ Overview page.